Do each of the listed research activities (rDNA, RG 2/3 infectious agents, select agents) in the IBC charge require full committee review and approval?
Recombinant DNA No, not all research activities require full IBC review. Current procedures allow the Campus Biological Safety Officer (BSO) to review and possibly approve designated rDNA research activities based on the NIH rDNA Guidelines as follows: The BSO is delegated authority to review and determine whether rDNA research is exempt, requires notice only to the IBC, or whether a full committee review is required. To make this determination, a BUA must be completed in enough detail for the BSO to evaluate the proposed research in context of the NIH rDNA Guidelines. Note: The rDNA NIH Guidelines are complex. The BUA is an essential tool in determining what sections of the NIH Guidelines apply to your research. Please submit requests for assistance to biosafety@ucsc.edu. Infectious Agents All research activities proposing use of RG 2 or 3 infectious agents require full IBC review. A BUA must be completed and submitted to biosafety@ucsc.edu to initiate the review process. Select Agent
Related Questions
- What is the relationship between research involving Select Agents and dual use research? Is there a relationship between the oversight systems for these two areas of research?
- Are collections agents required to complete any formal qualifications before they commence collections activities?
- How do I get approval for research involving human subjects, animals, hazardous materials, select agents, etc.?
